These compounds may interact with:
Corticotropin-releasing factor-binding protein
Potentially involved in: carcinoma; chronic kidney disease; alcohol dependence; alcoholic intoxication, chronic; bipolar disorder; mental depression; depressive disorder; unipolar depression; cocaine-related disorders; mood disorders; major depressive disorder; acute myeloid leukemia; adrenocortical carcinoma; astrocytic glioma; astrocytoma, pilocytic; ductal carcinoma in situ; ependymoma; fibroadenoma; glioblastoma; group 4 medulloblastoma
Disease data sourced from Pharos.